IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 4, Pages 873
Publisher
MDPI AG
Online
2020-04-07
DOI
10.3390/cells9040873
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Local intracerebral immunomodulation using interleukin-expressing mesenchymal stem cells in glioblastoma
- (2020) Malte Mohme et al. CLINICAL CANCER RESEARCH
- The IL-12– and IL-23–Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection
- (2019) Daria L. Ivanova et al. JOURNAL OF IMMUNOLOGY
- Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment
- (2018) Theresa L. Whiteside SEMINARS IN IMMUNOLOGY
- Intratumoral Delivery of Interferonγ-Secreting Mesenchymal Stromal Cells Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo
- (2018) Theresa Relation et al. STEM CELLS
- Inflammatory Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Stem Cell-Like Characteristics of Cancer Cells in an IL-1β-Dependent Manner
- (2018) Xiaohe Luo et al. Biomed Research International
- Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
- (2018) Daria S. Chulpanova et al. Frontiers in Pharmacology
- Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
- (2018) Andrea Ziblat et al. Frontiers in Immunology
- How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
- (2018) Alessandro Poggi et al. Frontiers in Immunology
- Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
- (2018) Giulia Golinelli et al. CANCER GENE THERAPY
- Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease
- (2017) Samantha F. H. de Witte et al. Stem Cell Research & Therapy
- Genetic Modification of T Cells with Chimeric Antigen Receptors: A Laboratory Manual
- (2017) Viktória Golumba-Nagy et al. Human Gene Therapy Methods
- T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC
- (2017) Arpad Szoor et al. Molecular Therapy-Oncolytics
- Interaction of MSC with tumor cells
- (2016) Catharina Melzer et al. Cell Communication and Signaling
- Key transcription factors in the differentiation of mesenchymal stem cells
- (2016) Sami G. Almalki et al. DIFFERENTIATION
- Superior Therapeutic Index in Lymphoma Therapy: CD30 + CD34 + Hematopoietic Stem Cells Resist a Chimeric Antigen Receptor T-cell Attack
- (2016) Andreas A Hombach et al. MOLECULAR THERAPY
- Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy
- (2016) Dylan E. Lee et al. Stem Cell Research & Therapy
- The paradoxical role of IL-10 in immunity and cancer
- (2015) Mark H. Mannino et al. CANCER LETTERS
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- TRAIL Based Therapy: Overview of Mesenchymal Stem Cell Based Delivery and miRNA Controlled Expression of TRAIL
- (2014) Rukset Attar et al. Asian Pacific Journal of Cancer Prevention
- Conventional NK Cells Can Produce IL-22 and Promote Host Defense in Klebsiella pneumoniae Pneumonia
- (2014) X. Xu et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice
- (2014) JIMING HAN et al. Experimental and Therapeutic Medicine
- Mesenchymal stem cell secretome and regenerative therapy after cancer
- (2013) Ludovic Zimmerlin et al. BIOCHIMIE
- Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition
- (2013) S. K. Perna et al. CLINICAL CANCER RESEARCH
- Effective Combination Therapy for Malignant Glioma with TRAIL-Secreting Mesenchymal Stem Cells and Lipoxygenase Inhibitor MK886
- (2012) S. M. Kim et al. CANCER RESEARCH
- Cancer-Related Inflammation
- (2012) Juliana Candido et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- CD28 Costimulation Impairs the Efficacy of a Redirected T-cell Antitumor Attack in the Presence of Regulatory T cells Which Can Be Overcome by Preventing Lck Activation
- (2011) David M Kofler et al. MOLECULAR THERAPY
- Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
- (2011) Ole Audun Werner Haabeth et al. Nature Communications
- Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc ‘spacer’ domain in the extracellular moiety of chimeric antigen receptors avoids ‘off-target’ activation and unintended initiation of an innate immune response
- (2010) A Hombach et al. GENE THERAPY
- Self-Inactivating Alpharetroviral Vectors with a Split-Packaging Design
- (2010) J. D. Suerth et al. JOURNAL OF VIROLOGY
- Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor
- (2010) Svetlana Komarova et al. Journal of Ovarian Research
- Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
- (2009) M. R. Loebinger et al. CANCER RESEARCH
- c-Jun Controls the Ability of IL-12 to Induce IL-10 Production from Human Memory CD4+ T Cells
- (2009) C. A. Garcia et al. JOURNAL OF IMMUNOLOGY
- Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface
- (2009) Irina V. Balyasnikova et al. Journal of Tissue Engineering and Regenerative Medicine
- Mutations in gp120 Contribute to the Resistance of Human Immunodeficiency Virus Type 1 to Membrane-Anchored C-Peptide maC46
- (2009) F. G. Hermann et al. JOURNAL OF VIROLOGY
- Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
- (2009) L. S. Sasportas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging
- (2009) Shannon Kidd et al. STEM CELLS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started